CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 10, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas,...
Hence then, the article about harbour biomed announces nmpa acceptance of ind application for hbm7004 for the treatment of advanced solid tumors was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Harbour BioMed Announces NMPA Acceptance of IND Application for HBM7004 for the Treatment of Advanced Solid Tumors )
Also on site :
- Scientists Reveal the Daily Step Count That May Delay Alzheimer’s by 7 Years
- Here’s What Jack Schlossberg Had to Say About Madonna’s Recent Revelations on JFK Jr. as a Lover: ‘All I Can Say Is…’
- Sam Bankman-Fried formally files for pardon—but White House reiterates that FTX cofounder’s odds are slim